RAMM Pharma Corp.

Ramm Pharma is a leader in the field of cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products with a unique and diversified international production and sales platform. The company operates an established pharmaceutical and medical product business in Uruguay that has developed several medically registered and approved plant-derived cannabinoid pharmaceutical products that have been authorized for sale and/or compassionate use in several Latin American countries. Ramm also has a pipeline of new products, including registered cannabis-based nutrition and specialized veterinary products, in various stages of approval and development, which are produced at the company’s state-of-the-art, good-manufacturing-practice-certified cannabis formulation facility in Montevideo, Uruguay.

Visit Website

Transactions

News

TORONTO, May 12, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH US NEWSWIRE SERVICES TORONTO, May 30, 2019 (GLOBE NEWSWIRE) -- Further to its news release dated May 3, 2019 announcing the proposed acquisition...

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH US NEWSWIRE SERVICES TORONTO, May 03, 2019 (GLOBE NEWSWIRE) -- MTC Growth Fund-I Inc (“MTC” or the “Corporation”) is pleased to...